Cargando…
Baseline CD3+CD56+ (NKT-like) Cells and the Outcome of Influenza Vaccination in Children Undergoing Chemotherapy
BACKGROUND: In children undergoing chemotherapy yearly influenza vaccination is recommended by treatment protocols. We investigated the relationship between cellular immunity and the antibody response to inactivated influenza vaccines. METHODS: 25 patients (age: 2-18 years) undergoing chemotherapy f...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276261/ https://www.ncbi.nlm.nih.gov/pubmed/34267757 http://dx.doi.org/10.3389/fimmu.2021.690940 |
_version_ | 1783721871041101824 |
---|---|
author | Leibinger, Evelin A. Pauler, Gábor Benedek, Noémi Berki, Tímea Jankovics, István McNally, Richard Ottóffy, Gábor |
author_facet | Leibinger, Evelin A. Pauler, Gábor Benedek, Noémi Berki, Tímea Jankovics, István McNally, Richard Ottóffy, Gábor |
author_sort | Leibinger, Evelin A. |
collection | PubMed |
description | BACKGROUND: In children undergoing chemotherapy yearly influenza vaccination is recommended by treatment protocols. We investigated the relationship between cellular immunity and the antibody response to inactivated influenza vaccines. METHODS: 25 patients (age: 2-18 years) undergoing chemotherapy for different malignancies participated in our study. Flow cytometric detection of peripheral blood lymphocyte subpopulations together with hemagglutination inhibition antibody titers were measured before and 21-28 days after vaccination. We examined the ratio and total numbers of CD3+, CD4+, CD8+ T cells, activated helper (CD3+CD4+CD25(low)), regulatory (CD3+CD4+CD25(high)), naive (CD3+CD45RA+) and memory (CD3+CD45RO+) T cells, CD56+NK, and CD3+CD56+ (NKT-like) cells. Relationships between specific antibody responses (seroprotection, seroconversion, geometric mean titer (GMT), geometric mean fold increase (GMFI)) and the ratios and counts of lymphocyte subpopulations were evaluated using one-way ANOVA and the paired sample t test after dichotomization according to age-related reference values. RESULTS: Patients with CD4+ lymphocyte levels in the normal age-specific range showed significantly better response regarding postvaccination GMT elevation for H1N1 and H3N2 strains (97.52 vs. 19.2, p=0.019, 80 vs. 14.43, p=0.021, respectively). GMFI results were significant only against B strain (2.69-fold vs. 1.23-fold, p=0.046). Prevaccination CD3+CD56+ (NKT-like) cells above predicted values according to age showed significant associations both in postvaccination GMT elevation (H1N1: 75.11 vs. 14.14, p=0.010; H3N2: 62.18 vs. 11.22, p=0.012; B: 22.69 vs. 6.67, p=0.043) and GMFI against all three strains (H1N1: 3.76-fold vs. 1.06-fold, p=0.015; H3N2: 2.74-fold vs. 1, p=0.013; B: 2.57-fold vs. 1, p=0.008). By one-way ANOVA, we found a positive relation between absolute lymphocyte cell count above 1000/µl and the postvaccination GMT elevation against H3N2 (12.81 vs. 56.56, p=0.032), and GMFI regarding H1N1 (1.22-fold vs. 3.48-fold, p=0.044). CONCLUSIONS: In addition to verifying the predictive value of absolute lymphocyte count above 1000/µl, our results suggest an association between NKT-like cell counts and the specific antibody response against all three investigated influenza strains in highly immunosuppressed patients. Furthermore, prevaccination CD4+ lymphocyte levels in the normal age-specific range may influence seroresponse. |
format | Online Article Text |
id | pubmed-8276261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82762612021-07-14 Baseline CD3+CD56+ (NKT-like) Cells and the Outcome of Influenza Vaccination in Children Undergoing Chemotherapy Leibinger, Evelin A. Pauler, Gábor Benedek, Noémi Berki, Tímea Jankovics, István McNally, Richard Ottóffy, Gábor Front Immunol Immunology BACKGROUND: In children undergoing chemotherapy yearly influenza vaccination is recommended by treatment protocols. We investigated the relationship between cellular immunity and the antibody response to inactivated influenza vaccines. METHODS: 25 patients (age: 2-18 years) undergoing chemotherapy for different malignancies participated in our study. Flow cytometric detection of peripheral blood lymphocyte subpopulations together with hemagglutination inhibition antibody titers were measured before and 21-28 days after vaccination. We examined the ratio and total numbers of CD3+, CD4+, CD8+ T cells, activated helper (CD3+CD4+CD25(low)), regulatory (CD3+CD4+CD25(high)), naive (CD3+CD45RA+) and memory (CD3+CD45RO+) T cells, CD56+NK, and CD3+CD56+ (NKT-like) cells. Relationships between specific antibody responses (seroprotection, seroconversion, geometric mean titer (GMT), geometric mean fold increase (GMFI)) and the ratios and counts of lymphocyte subpopulations were evaluated using one-way ANOVA and the paired sample t test after dichotomization according to age-related reference values. RESULTS: Patients with CD4+ lymphocyte levels in the normal age-specific range showed significantly better response regarding postvaccination GMT elevation for H1N1 and H3N2 strains (97.52 vs. 19.2, p=0.019, 80 vs. 14.43, p=0.021, respectively). GMFI results were significant only against B strain (2.69-fold vs. 1.23-fold, p=0.046). Prevaccination CD3+CD56+ (NKT-like) cells above predicted values according to age showed significant associations both in postvaccination GMT elevation (H1N1: 75.11 vs. 14.14, p=0.010; H3N2: 62.18 vs. 11.22, p=0.012; B: 22.69 vs. 6.67, p=0.043) and GMFI against all three strains (H1N1: 3.76-fold vs. 1.06-fold, p=0.015; H3N2: 2.74-fold vs. 1, p=0.013; B: 2.57-fold vs. 1, p=0.008). By one-way ANOVA, we found a positive relation between absolute lymphocyte cell count above 1000/µl and the postvaccination GMT elevation against H3N2 (12.81 vs. 56.56, p=0.032), and GMFI regarding H1N1 (1.22-fold vs. 3.48-fold, p=0.044). CONCLUSIONS: In addition to verifying the predictive value of absolute lymphocyte count above 1000/µl, our results suggest an association between NKT-like cell counts and the specific antibody response against all three investigated influenza strains in highly immunosuppressed patients. Furthermore, prevaccination CD4+ lymphocyte levels in the normal age-specific range may influence seroresponse. Frontiers Media S.A. 2021-06-29 /pmc/articles/PMC8276261/ /pubmed/34267757 http://dx.doi.org/10.3389/fimmu.2021.690940 Text en Copyright © 2021 Leibinger, Pauler, Benedek, Berki, Jankovics, McNally and Ottóffy https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Leibinger, Evelin A. Pauler, Gábor Benedek, Noémi Berki, Tímea Jankovics, István McNally, Richard Ottóffy, Gábor Baseline CD3+CD56+ (NKT-like) Cells and the Outcome of Influenza Vaccination in Children Undergoing Chemotherapy |
title | Baseline CD3+CD56+ (NKT-like) Cells and the Outcome of Influenza Vaccination in Children Undergoing Chemotherapy |
title_full | Baseline CD3+CD56+ (NKT-like) Cells and the Outcome of Influenza Vaccination in Children Undergoing Chemotherapy |
title_fullStr | Baseline CD3+CD56+ (NKT-like) Cells and the Outcome of Influenza Vaccination in Children Undergoing Chemotherapy |
title_full_unstemmed | Baseline CD3+CD56+ (NKT-like) Cells and the Outcome of Influenza Vaccination in Children Undergoing Chemotherapy |
title_short | Baseline CD3+CD56+ (NKT-like) Cells and the Outcome of Influenza Vaccination in Children Undergoing Chemotherapy |
title_sort | baseline cd3+cd56+ (nkt-like) cells and the outcome of influenza vaccination in children undergoing chemotherapy |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276261/ https://www.ncbi.nlm.nih.gov/pubmed/34267757 http://dx.doi.org/10.3389/fimmu.2021.690940 |
work_keys_str_mv | AT leibingerevelina baselinecd3cd56nktlikecellsandtheoutcomeofinfluenzavaccinationinchildrenundergoingchemotherapy AT paulergabor baselinecd3cd56nktlikecellsandtheoutcomeofinfluenzavaccinationinchildrenundergoingchemotherapy AT benedeknoemi baselinecd3cd56nktlikecellsandtheoutcomeofinfluenzavaccinationinchildrenundergoingchemotherapy AT berkitimea baselinecd3cd56nktlikecellsandtheoutcomeofinfluenzavaccinationinchildrenundergoingchemotherapy AT jankovicsistvan baselinecd3cd56nktlikecellsandtheoutcomeofinfluenzavaccinationinchildrenundergoingchemotherapy AT mcnallyrichard baselinecd3cd56nktlikecellsandtheoutcomeofinfluenzavaccinationinchildrenundergoingchemotherapy AT ottoffygabor baselinecd3cd56nktlikecellsandtheoutcomeofinfluenzavaccinationinchildrenundergoingchemotherapy |